In reply: MAO inhibitors
Cleveland Clinic Journal of Medicine. 2011 February;78(2):81
February 1, 2011|Cleveland Clinic Journal of Medicine
Author and Disclosure Information
In Reply: Dr. Keller is correct, and we thank him for the clarification. We meant to say that selegiline is the only selective MAO-B inhibitor indicated for treating depression in the United States.
